This profile is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any compound.
What Is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that was first isolated from human plasma in 1973 by researcher Loren Pickart. It is found throughout the body — in plasma, saliva, and urine — at highest concentrations during youth, declining significantly with advancing age. At age 20, plasma concentrations hover around 200 ng/mL; by age 60, they have fallen to approximately 80 ng/mL. This age-related decline is strongly correlated with the reduced regenerative capacity and wound healing ability observed in older individuals, making GHK-Cu a compelling target for anti-aging and tissue repair research.
The peptide's unique feature is its ability to form a stable complex with copper (Cu2+), a trace mineral that is an essential cofactor for numerous enzymes involved in collagen cross-linking, antioxidant defense, and melanin production. In its copper-bound form, GHK-Cu is significantly more biologically active than the peptide alone, and the complex is what is typically sold and researched as "GHK-Cu." It is one of the few peptides that has demonstrated efficacy through both topical application (where it penetrates the skin) and systemic (subcutaneous) administration.
Research by Pickart and others has revealed that GHK-Cu modulates the expression of over 4,000 human genes — approximately one-third of the human genome — with effects that broadly favor tissue restoration, antioxidant defense, and anti-inflammatory signaling. This remarkable genomic footprint distinguishes it from narrow-acting peptides and positions it as a multi-system repair signal with genuine anti-aging relevance.
How It Works
GHK-Cu's primary mechanism in skin and connective tissue involves the activation of TGF-β (transforming growth factor beta) signaling, which drives fibroblasts to produce collagen, elastin, and glycosaminoglycans — the structural proteins that give skin its firmness and connective tissue its tensile strength. It also upregulates the activity of matrix metalloproteinases (MMPs), enzymes that break down damaged and disorganized collagen, while simultaneously promoting synthesis of new, well-organized collagen fibers. This dual action — clearing the old and building the new — leads to genuine tissue remodeling rather than simple stimulation of collagen deposition.
GHK-Cu's copper component activates lysyl oxidase, an enzyme responsible for cross-linking collagen and elastin fibers to give them structural integrity. Without adequate copper-dependent cross-linking, newly synthesized collagen is weak and poorly organized. By delivering copper directly to the sites of synthesis, GHK-Cu ensures that the collagen produced is functionally superior. The peptide also potently upregulates antioxidant enzymes including superoxide dismutase (SOD) and catalase, protecting cells from the oxidative damage that accumulates with aging and slows healing.
Angiogenesis is another key mechanism: GHK-Cu stimulates VEGF expression, promoting the formation of new blood vessels in healing tissue. This vascular support is critical for delivering nutrients and oxygen to repair sites, particularly in skin tissue where poor circulation is a major barrier to effective healing in aging individuals.
Key Benefits Discussed in Research
Dosing Reference (Educational Only)
All dosing information is derived from research literature and community experience. Consult a qualified healthcare provider before starting any protocol.
| Parameter | Common Research Range | Notes |
|---|---|---|
| Topical Concentration | 1–5% cream or serum | Start at 1–2% to assess skin tolerance; higher concentrations for accelerated wound healing |
| Topical Frequency | Once to twice daily | Apply after cleansing; can be layered under moisturizer; avoid eyes |
| Injectable Dose | 1–2 mg per week (SubQ) | Less commonly used; preferred for systemic connective tissue or nerve repair goals |
| Injectable Cycle | 8–12 weeks, then reassess | Topical use can continue indefinitely given the favorable safety profile |
| Topical Vehicle | Liposomal serum preferred | Liposomal encapsulation enhances skin penetration depth significantly |
| Storage | Refrigerate; avoid oxidation | GHK-Cu can oxidize and turn blue-green — discard if significant color change occurs |
Want the Full GHK-Cu Protocol?
Join SDBioHack and access community-validated protocols, sourcing checklists, and expert Q&A.
Side Effects & Safety Profile
GHK-Cu has an excellent safety record across both topical and injectable use in the research literature. Topical application occasionally causes mild redness or skin irritation, particularly at higher concentrations (3–5%), which usually resolves after a brief adjustment period or dose reduction. Skin discoloration (blue-green staining) from oxidized peptide is cosmetic and temporary. No systemic toxicity has been attributed to topical GHK-Cu use. The peptide's role as a naturally occurring plasma constituent further supports its biocompatibility.
Injectable GHK-Cu is less studied in humans but generally well-tolerated anecdotally. The primary risks are those inherent to any subcutaneous injection: site reactions, bruising, and infection risk from non-sterile technique. No hormonal suppression, organ toxicity, or significant drug interactions have been identified in the available literature. Its broad gene modulation activity is sometimes cited as a theoretical concern, but the directionality of these effects in research is consistently toward health restoration rather than disruption.
- Avoid application to broken or acutely inflamed skin until the acute phase has passed.
- Copper accumulation: individuals with Wilson's disease (impaired copper metabolism) should avoid GHK-Cu.
- Pregnancy and breastfeeding: insufficient data; avoid systemic use.
- Do not combine topical GHK-Cu with strong acids (vitamin C at low pH) simultaneously — wait 20–30 minutes between applications to avoid peptide degradation.
Common Stacks & Pairings
For topical anti-aging and skin remodeling, GHK-Cu is frequently layered with Matrixyl (palmitoyl pentapeptide-4), which also targets collagen synthesis through a complementary TGF-β pathway, and Argireline (acetyl hexapeptide-3), which reduces expression lines by relaxing facial muscle activity. For injectable protocols targeting systemic tissue repair, GHK-Cu pairs well with BPC-157 to cover both musculoskeletal healing and extracellular matrix remodeling. Retinol (vitamin A) and GHK-Cu are a popular dermatology-adjacent combination, though they should be applied at separate times to prevent irritation.
Frequently Asked Questions
The blue-green color is characteristic of oxidized copper in the GHK-Cu complex. Some color variation is normal, but significant darkening or color change suggests the peptide has begun to degrade. To minimize oxidation, store GHK-Cu in amber glass containers, keep refrigerated, and minimize air exposure. A pale blue tint is normal and not a sign of spoilage; a deep blue-green with altered consistency suggests it is time to replace the product.
Research is promising but not conclusive for human hair regrowth. Studies have shown GHK-Cu can enlarge miniaturized follicles, extend the anagen growth phase, and stimulate follicle cell proliferation in vitro and in animal models. Some small human studies have shown improvements in hair density when GHK-Cu was applied topically to the scalp. It is not a proven treatment for androgenic alopecia on par with minoxidil or finasteride, but it is used by many practitioners as a supportive addition to broader hair health protocols.
For first-time users, a 1–2% concentration is recommended to assess skin tolerance. Most commercially available GHK-Cu serums fall in the 1–3% range, which is well-tolerated by the majority of users. Higher concentrations (3–5%) are used in targeted wound healing or hair loss protocols but carry a slightly higher risk of irritation for sensitive skin types. Applying to a small patch of skin for 24–48 hours before full use is always advisable with any new topical peptide.
The two routes serve different purposes. Topical GHK-Cu is most appropriate for skin-specific goals — collagen synthesis, wrinkle reduction, wound healing, and hair follicle support. Subcutaneous injection provides systemic distribution, making it more applicable to broader tissue repair goals such as connective tissue remodeling or nerve regeneration throughout the body. For purely aesthetic skin goals, high-quality topical formulations in liposomal vehicles are often preferred due to their ease of use and the ability to target specific skin areas directly.
Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." International Journal of Molecular Sciences. 2018;19(7):1987.
Hostynek JJ, et al. "Human skin retention and penetration of a copper tripeptide in vitro as a function of skin layer." Skin Pharmacology and Physiology. 2010;23(6):299–306.
Pickart L, et al. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." BioMed Research International. 2015;2015:648108.
Finkley MB, et al. "The effect of the human plasma fraction, GHK, on hair follicle growth in vitro." Skin Pharmacology. 1992;5(3):218–221.